Lifespan Edge, a next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, has announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland. A third premier destination is planned for Scottsdale, Arizona, according to a press release from the company.
Each clinic delivers a concierge-style, physician-led model that combines advanced diagnostics with personalized prevention strategies. The approach aims to support performance, healthy aging, and long-term wellness for clients. Lifespan Edge positions itself as a leader in the growing field of longevity medicine, which focuses on extending healthspan—the period of life spent in good health—rather than merely lifespan.
The company highlights research into Therapeutic Plasma Exchange (TPE), a procedure that involves replacing a patient's blood plasma with a substitute. Citing findings from the AMBAR (Alzheimer's Management by Albumin Replacement) trial, Lifespan Edge notes that TPE has shown promise in slowing aspects of cognitive and functional decline in Alzheimer's patients. However, the company emphasizes the need for further study before the therapy can be widely recommended.
Lifespan Edge is building what it describes as the world's most comprehensive TPE database, aiming to pioneer new advancements in longevity science. This focus on research and innovation distinguishes the clinic from more traditional wellness centers, which often lack such a data-driven approach.
The expansion into Florida and Maryland comes as demand for longevity and preventive health services grows, particularly among affluent individuals and business leaders. By offering a concierge model, Lifespan Edge targets those who can afford personalized, high-touch medical care. The company's co-founders bring significant credibility: John Mauldin is a well-known financial futurist and author, while Dr. Michael Roizen is a former chief wellness officer at the Cleveland Clinic and a pioneer in preventive medicine.
For leaders in business and technology, the trend toward longevity clinics represents both a personal health opportunity and a potential market shift. As more companies and individuals invest in extending healthspan, industries from insurance to pharmaceuticals may need to adapt. Lifespan Edge's focus on TPE and data collection could also accelerate research into aging-related diseases, potentially impacting public health policies and healthcare costs.
The new locations are expected to serve clients in the Southeast and Mid-Atlantic regions, with the planned Scottsdale site targeting the Southwest. For more information, the full announcement is available at Newsworthy.ai, distributed by Reportable, Inc.
